scholarly journals Availability and Usability of Behavioral Health Organization Encounter Data in MAX 2009

2014 ◽  
Vol 4 (2) ◽  
pp. E1-E12 ◽  
Author(s):  
Jessica Nysenbaum ◽  
Ellen Bouchery ◽  
Rosalie Malsberger

This book provides detailed information about successful collaborations between universities and public behavioral health organizations in criminal justice contexts. The authors begin by introducing the relevant purpose and definitions and then describe each of the nine contributed chapters to follow. Each of these chapters describes a particular collaboration between a university and a public behavioral health organization. Each chapter is structured around a description of the collaboration’s purposes, beginning, leadership, who is served, services, operations, effectiveness measurement, financial arrangements, and lessons learned. Collaborative projects were selected because they were long-standing and successful. The descriptions provided by each project are then aggregated into a larger model for success. This is detailed in the final chapter with a distillation of “lessons learned” in building, operating, and sustaining a successful collaboration. These lessons are provided in particular areas: planning, working together, training, consultation, financial considerations, personnel, and research. By considering these nine exemplary projects and the final “lessons learned,” this book has implications for comparable collaborations between universities and public behavioral health organizations in a criminal justice context.


2001 ◽  
Vol 52 (11) ◽  
pp. 1428-1428 ◽  
Author(s):  
Marilyn L. Matevia ◽  
Debby Poon ◽  
William Goldman ◽  
Brian Cuffel ◽  
Joyce McCulloch

Author(s):  
Samuel H. Zuvekas ◽  
Agnes E. Rupp ◽  
Grayson S. Norquist

This paper extends the previous literature examining the impacts of managed behavioral health care carve-outs and mental health parity mandates on mental health and substance abuse (MH/SA) specialty treatment use and costs by considering the effects on psychotropic prescription medication costs. We use multivariate panel data methods to remove underlying secular growth trends, driven by increased demand for improved MH/SA treatment related to pharmaceutical innovations. We find that psychotropic medication costs continued to increase after the introduction of a substantial benefit expansion and carve-out to a managed behavioral health organization (MBHO), offsetting large declines in inpatient specialty MH/SA costs. However, we find evidence that the MBHO may have restrained growth in prescription medication spending.


2000 ◽  
Vol 51 (10) ◽  
pp. 1273-1277 ◽  
Author(s):  
Burton Reifler ◽  
Judy Briggs ◽  
Peter Rosenquist ◽  
Heather Uncapher ◽  
Christopher Colenda ◽  
...  

Author(s):  
Kimberly A. Hepner ◽  
Gregory L. Greenwood ◽  
Francisca Azocar ◽  
Jeanne Miranda ◽  
M. Audrey Burnam

Sign in / Sign up

Export Citation Format

Share Document